Insider Sells Shares Under 10b5-1 Plan (NYSE: RDDT)

Rhea-AI Filing Summary

Christopher Brian Slowe reported insider sales activity and a proposed sale on a Form 144. The filing lists 55,036 shares to be sold arising from an exercise of stock options dated 02/23/2026 and 38,000 Restricted Stock Units with grant date 03/21/2024. The filing also discloses prior 10b5-1 sales: 11,464 shares on 02/10/2026, 14,000 on 01/22/2026, 14,000 on 01/08/2026, 14,000 on 12/22/2025, 14,000 on 12/08/2025, and 24,000 on 11/24/2025, each showing corresponding proceeds in dollars.

Insights

Corporate Governance Analyst

Routine 10b5-1 sales and a Form 144 covering option-derived shares and RSUs.

The filing lists a proposed disposition of 55,036 shares tied to an exercise of stock options (dated 02/23/2026) and records 38,000 Restricted Stock Units with grant date 03/21/2024. Several executed 10b5-1 sales between 11/24/2025 and 02/10/2026 are itemized with share counts and dollar proceeds.

These entries are typical for scheduled insider dispositions; cash flows appear to accrue to the selling holder. Timing and broader ownership impact are not disclosed in the excerpt; subsequent filings may clarify remaining beneficial ownership.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	93036	13971216.12	139649508	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Exercise of Stock Options	Issuer			55036	02/23/2026	Cash
Common	03/21/2024	Restricted Stock Units	Issuer			38000	03/21/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	02/10/2026	11464	1716664.27
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	01/22/2026	14000	2976542.60
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	01/08/2026	14000	3554396.40
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	12/22/2025	14000	3269347.80
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	12/08/2025	14000	3275827.20
10b5-1 Sales for CHRISTOPHER BRIAN SLOWE 303 2nd Street, South Tower, 5th Floor San Francisco CA 94107	Common	11/24/2025	24000	4625205.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 filed for RDDT disclose?

The Form 144 disclosed proposed and completed insider sales of common stock. It lists a proposed sale of 55,036 shares from an option exercise and 38,000 RSUs (grant date 03/21/2024), plus multiple prior 10b5-1 sales with dates and proceeds.

Which prior 10b5-1 sales are listed in the filing?

The filing lists six prior 10b5-1 transactions with share counts and proceeds. Examples: 11,464 shares on 02/10/2026 and 14,000 shares on 01/22/2026; each entry shows the dollar proceeds alongside the share amount.

Who is the reporting person on this Form 144?

The reporting person named is Christopher Brian Slowe. The entries show multiple 10b5-1 sales attributed to him and a proposed sale tied to option exercise dated 02/23/2026 as listed on the form.

Does the filing state who receives the sale proceeds?

The filing shows dollar proceeds for each executed 10b5-1 sale but does not specify recipient wording beyond the selling holder. Cash-flow treatment is identified as proceeds associated with each sale amount in the form entries.

Are the listed RSUs being sold now or are they context for the filing?

The form lists 38,000 Restricted Stock Units with grant date 03/21/2024 in the securities section. The RSU line is included in the filing alongside the proposed option-derived sale; the filing ties the RSUs to the issuer but does not state an immediate sale execution in the excerpt.